Document Preview Unavailable

Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial

Dar, Huma; Johansson, Annelie; Nordenskjöld, Anna; Iftimi, Adina; Yau, Christina; et al.  JAMA Network Open Vol. 4, Iss. 6,  (2021): e2114904.

You might have access to this document